Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 1, 2020
- Accepted for publication September 26, 2020
- Published online January 29, 2021.
Article Versions
- Earlier version (December 7, 2020 - 08:43).
- Earlier version (December 10, 2020 - 10:42).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2021 by the American Society of Nephrology
Author Information
- Robert Toto1,
- Jeffrey Petersen2,
- Jeffrey S. Berns3,
- Eldrin Foster Lewis4,
- Qui Tran2 and
- Matthew R. Weir5
- 1University of Texas Southwestern Medical Center, Dallas, Texas
- 2Amgen Inc., Thousand Oaks, California
- 3Perelman School of Medicine at the University of Pennsylvania and Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
- 4Stanford University Medical School, Stanford, California
- 5Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
- Correspondence:
Dr. Robert Toto, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas Texas 75230. Email: Robert.toto{at}utsouthwestern.edu
Funding
Amgen
National Institutes of Health
R01DK066013; R01HL147422; R01132732; U01DK106102; U01116095
Statistics from Altmetric.com
Article usage
In this issue
A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD
Jump to section
More in this TOC Section
Cited By...
- No citing articles found.